Oppenheimer lowered the firm’s price target on Varex Imaging (VREX) to $18 from $23 and keeps an Outperform rating on the shares. The firm notes Varex’s Q4 revenues of $229M came in ahead of its/consensus $221M/$219M estimates and on the high end of the $210M-$230M guide. Varex also reported Q1 2026 revenue guidance of $200M-$215M, bracketing Oppenheimer/consensus $207/$206M estimates.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VREX: